首页> 美国卫生研究院文献>Biochemical Journal >Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic but not transferrin-receptor-mediated iron uptake.
【2h】

Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic but not transferrin-receptor-mediated iron uptake.

机译:溶质载体11a1(Slc11a1;以前为Nramp1)调节吞噬细胞(而非运铁蛋白受体介导的铁摄取)获得的铁的代谢和释放。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Solute carrier 11a1 (Slc11a1; formerly Nramp1; where Nramp stands for natural-resistance-associated macrophage protein) is a proton/bivalent cation antiporter that localizes to late endosomes/lysosomes and controls resistance to pathogens. In the present study the role of Slc11a1 in iron turnover is examined in macrophages transfected with Slc11a1(Gly169) (wild-type) or Slc11a1(Asp169) (mutant=functional null) alleles. Following direct acquisition of transferrin (Tf)-bound iron via the Tf receptor, iron uptake and release was equivalent in wild-type and mutant macrophages and was not influenced by interferon-gamma/lipopolysaccharide activation. Following phagocytosis of [(59)Fe]Tf-anti-Tf immune complexes, iron uptake was equivalent and up-regulated similarly with activation, but intracellular distribution was markedly different. In wild-type macrophages most iron was in the soluble (60%) rather than insoluble (12%) fraction, with 28% ferritin (Ft)-bound. With activation, the soluble component increased to 82% at the expense of Ft-bound iron (<5%). In mutant macrophages, 40-50% of iron was in insoluble form, 50-60% was soluble and <5% was Ft-bound. Western-blot analysis confirmed failure of mutant macrophages to degrade complexes 24 h after phagocytic uptake. Confocal microscopy showed that complexes were within lysosome-associated membrane protein 1-positive vesicles in wild-type and mutant macrophages at 30 min and 24 h, implying failure in the degradative process in mature phagosomes in mutant macrophages. NO-mediated iron release was 2.4-fold higher in activated wild-type macrophages compared with mutant macrophages. Overall, our data suggest that iron acquired by phagocytosis and degradation is retained within the phagosomal compartment in wild-type macrophages, and that NO triggers iron release by direct secretion of phagosomal contents rather than via the cytoplasm.
机译:溶质载体11a1(Slc11a1;以前为Nramp1;其中Nramp代表与自然抗性相关的巨噬细胞蛋白)是质子/二价阳离子反转运蛋白,其定位于晚期内体/溶酶体并控制对病原体的抗性。在本研究中,在用Slc11a1(Gly169)(野生型)或Slc11a1(Asp169)(突变体=功能无效)等位基因转染的巨噬细胞中检查了Slc11a1在铁转换中的作用。通过Tf受体直接获得与运铁蛋白(Tf)结合的铁后,铁的摄取和释放在野生型和突变型巨噬细胞中是等效的,不受干扰素-γ/脂多糖激活的影响。 [(59)Fe] Tf-抗-Tf免疫复合物的吞噬作用后,铁的摄取是相同的,并且与激活类似地被上调,但是细胞内分布明显不同。在野生型巨噬细胞中,大多数铁是可溶的(60%)而不是不溶的(12%),其中28%的铁蛋白(Ft)结合。通过活化,可溶性成分增加至82%,但以Ft结合的铁(<5%)为代价。在突变型巨噬细胞中,40-50%的铁为不溶形式,50-60%的为可溶形式,<5%为Ft结合。 Western印迹分析证实吞噬细胞摄取后24小时突变巨噬细胞未能降解复合物。共聚焦显微镜显示,复合物在30分钟和24小时内位于野生型和突变型巨噬细胞的溶酶体相关膜蛋白1阳性囊泡中,这意味着突变型巨噬细胞中成熟吞噬体的降解过程失败。与突变巨噬细胞相比,在活化的野生型巨噬细胞中NO介导的铁释放高2.4倍。总体而言,我们的数据表明,通过吞噬作用和降解而获得的铁被保留在野生型巨噬细胞的吞噬体隔室内,并且NO通过吞噬体内容物的直接分泌而不是通过细胞质触发铁释放。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号